When two ace stock pickers take diametrically opposite views about a stock, it puts us in a precarious position. We need to stay alert to the situation and take appropriate action
Posts tagged Daljeet Kohli
Take Advantage Of Russian Crises To Buy JB Chem For 50% Gain: Daljeet Kohli
JB Chem has been battered due to the currency crises in Russia. This presents an opportunity for us to tuck into this fundamentally strong Pharma company says Daljeet Kohli
Sharon Bio-Medicine Price Target Slashed & Downgraded To Hold: Daljeet Kohli
Daljeet Kohli has slashed the target price of Sharon Bio-Medicine from Rs. 140 to Rs. 66. Though there is still a huge potential upside, he has downgraded the stock to ‘Hold’ to await clarity of future events
Suven Life Sciences & Shilpa Medicare: From Multi-baggers To 100-Baggers?
Two stocks we are familiar with, Suven Life Sciences & Shilpa Medicare, have been given the distinction of being potential 100-baggers. These stocks have already put up a tremendous performance and there is no need to doubt their future potential
Sharon Bio-Medicine Is “Under Review”: Daljeet Kohli
Sharon Bio-Medicine’s savage fall of 20% yesterday appears to have shaken Daljeet Kohli. He has issued a terse note that he is investigating the cause of the fall and that the stock is “under review” till then
Daljeet Kohli Makes Big Bucks From Mastek And Loses Big Bucks To Sharon Bio-Medicine
Today was a day of mixed feelings for Daljeet Kohli. While Mastek surged 20% to hit the UC, Sharon Bio-Medicine plunged 20% to hit the LC
The Stock Picks Of Daljeet Kohli Of IndiaNivesh
Daljeet Kohli of IndiaNivesh has revealed his favourite stocks in interviews to ETNow & Business Standard
Daljeet Kohli Makes A Packet from OnMobile Global & Pennar Industries. Sees More Gains From Them
Daljeet Kohli’s latest stock picks, OnMobile Global and Pennar Industries, are steadily churning out gains for investors. He has issued an update promising more gains from these stocks
Sharon Bio-Medicine Has 174%+ Upside: Daljeet Kohli
Daljeet Kohli of IndiaNivesh has issued an update report pointing out that the 40% correction in the stock has made the stock attractive in terms of valuation. He has foreseen a target of Rs. 140 for the stock and advised investors to wait for the results of key near term triggers
KPR Mills Has 54% Upside: Daljeet Kohli Of IndiaNivesh
Daljeet Kohli & Prerna Jhunjhunwala of IndiaNivesh have issued an Initiating Coverage report on KPR Mills Ltd and claimed that the stock has an upside of 54% from the CMP of Rs. 370
Recent Comments